Amyotrophic lateral sclerosis
Not recruitingStudy on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
Study on the Safety and Effectiveness of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) for Adults with Amyotrophic Lateral Sclerosis (ALS)
- Disease:Amyotrophic lateral sclerosis
- Substances:PhenylbutyrateUrsodoxicoltaurine
France- Participants:18–64 years · 65+ years
- Substances:Phenylbutyrate
- Sponsor:Amylyx Pharmaceuticals Inc.












